Yes. I was glad to see the decision to have the data independently reviewed and I look forward very much to those findings. I do think MANF is likely to be successful... and quite possibly a huge indication... the science is intriguing, but as you point out... still many unanswered questions...
I agree also that the licensing deal for the diagnostics could well fund clinical work reducing the risk of dilution...
When do you see monetization of the diagnostics, i.e. licensing deal... if all is confirmed in trials... I am guessing 2014... I have seen estimates for year end 2013... but my experience in this sector suggests things always take longer... delays are like breathing in this space... patience is a prerequisite to success...
Market Data 
Markets 
AI
